peroxynitrous acid has been researched along with 1-naphthylamine in 2 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (1-naphthylamine) | Trials (1-naphthylamine) | Recent Studies (post-2010) (1-naphthylamine) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 1,088 | 137 | 194 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, M; Kaundal, RK; Kumar, A; Sharma, SS | 1 |
| Kumar, A; Negi, G; Sharma, SS | 1 |
2 other study(ies) available for peroxynitrous acid and 1-naphthylamine
| Article | Year |
|---|---|
Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes.
Topics: 1-Naphthylamine; Animals; Antioxidants; Diabetic Neuropathies; Male; Malondialdehyde; NAD; Naphthalimides; Neural Conduction; Neuralgia; Neuroprotective Agents; Oxidative Stress; Pain Measurement; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Quinolones; Rats; Rats, Sprague-Dawley; Resveratrol; Sciatic Nerve; Stilbenes | 2009 |
Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
Topics: 1-Naphthylamine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; DNA Damage; Male; Metalloporphyrins; Naphthalimides; Oxidative Stress; Peripheral Nerves; Peroxynitrous Acid; Poly(ADP-ribose) Polymerase Inhibitors; Quinolones; Rats; Rats, Sprague-Dawley | 2010 |